Occult metastasis is no burden factor in oral squamous cell carcinoma patients when adhering to a standardized approach in neck dissection.

Lymph node metastasis Neck dissection Occult metastasis Oral squamous cell carcinoma

Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
24 Jan 2024
Historique:
received: 15 11 2023
accepted: 16 01 2024
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 24 1 2024
Statut: epublish

Résumé

Management of the neck in patients with oral squamous cell carcinoma (OSCC) is pivotal to oncologic control and survival. However, there is controversy regarding necessity of neck dissection (ND) in patients with clinically node-negative neck. We aimed to assess risk factors for occult metastasis and to explore whether the presence of occult lymph node metastases (LNMs) has an impact on recurrence and survival. A retrospective cohort study was performed including patients with primary OSCC who underwent radical tumor resection and ND in a high-volume center adhering to the prevailing German guideline. The ND was performed according to a standardized approach. Four hundred twenty-one patients with primary surgically treated OSCC were included. The incidence of occult metastasis was 14.49%. A pathological T stage > 1 (multivariate analysis, odds ratio (OR) 3.958, p = 0.042) and the presence of extranodal extension in LNMs (multivariate analysis, OR 0.287, p = 0.020) were identified as independent risk factors for occult metastasis. When comparing patients with and without occult metastasis, there were no significant differences in terms of progression-free survival (log-rank, p = 0.297) and overall survival (log-rank, p = 0.320). There were no cases of ipsilateral neck recurrence. One patient developed contralateral neck metastasis; however, he initially presented with a unilateral pT1 pN0 tumor. Overall, our findings suggest that conducting a standardized approach in ND should be applied in terms of management of the neck in order to maintain survival rates and to prevent neck recurrence in OSCC patients. None of the risk factors for occult metastasis can be reliably assessed preoperatively. Although elective ND does not guarantee the complete prevention of neck recurrence, it increases the likelihood of either timely removal of micrometastases or strengthens the justification for adjuvant therapy. Consequently, this approach leads to improvements in clinical outcomes.

Identifiants

pubmed: 38267767
doi: 10.1007/s00784-024-05514-8
pii: 10.1007/s00784-024-05514-8
doi:

Types de publication

Journal Article

Langues

eng

Pagination

113

Informations de copyright

© 2024. The Author(s).

Références

Massano J, Regateiro FS, Januario G, Ferreira A (2006) Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:67–76. https://doi.org/10.1016/j.tripleo.2005.07.038
doi: 10.1016/j.tripleo.2005.07.038 pubmed: 16831675
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941–1953. https://doi.org/10.1002/ijc.31937
doi: 10.1002/ijc.31937 pubmed: 30350310
Moratin J, Horn D, Metzger K, Ristow O, Flechtenmacher C, Engel M, Hoffmann J, Freier K, Freudlsperger C (2020) Squamous cell carcinoma of the mandible - patterns of metastasis and disease recurrence in dependence of localization and therapy. J Craniomaxillofac Surg 48:1158–1163. https://doi.org/10.1016/j.jcms.2020.10.006
doi: 10.1016/j.jcms.2020.10.006 pubmed: 33199211
Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue–clinicopathologic features affecting outcome. Cancer 118:101–111. https://doi.org/10.1002/cncr.26229
doi: 10.1002/cncr.26229 pubmed: 21717431
Crile G (1906) III. On the technique of operations upon the head and neck. Ann Surg 44:842–850. https://doi.org/10.1097/00000658-190612000-00003
doi: 10.1097/00000658-190612000-00003 pubmed: 17861894 pmcid: 1414224
Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C (1980) Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer 46:386–390. https://doi.org/10.1002/1097-0142(19800715)46:2%3c386::aid-cncr2820460229%3e3.0.co;2-9
doi: 10.1002/1097-0142(19800715)46:2<386::aid-cncr2820460229>3.0.co;2-9 pubmed: 6992980
Huang SF, Chang JT, Liao CT, Kang CJ, Lin CY, Fan KH, Wang HM, Chen IH (2015) The role of elective neck dissection in early stage buccal cancer. Laryngoscope 125:128–133. https://doi.org/10.1002/lary.24840
doi: 10.1002/lary.24840 pubmed: 25043680
Ebrahimi A, Ashford BG, Clark JR (2012) Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma. Head Neck 34:709–716. https://doi.org/10.1002/hed.21809
doi: 10.1002/hed.21809 pubmed: 21739519
Cai H, Zhu Y, Wang C, Zhang Y, Hou J (2020) Neck nodal recurrence and survival of clinical T1–2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 129:296–310. https://doi.org/10.1016/j.oooo.2019.10.012
doi: 10.1016/j.oooo.2019.10.012 pubmed: 32107184
Struckmeier AK, Yekta E, Agaimy A, Kopp M, Buchbender M, Moest T, Lutz R, Kesting M (2023) Diagnostic accuracy of contrast-enhanced computed tomography in assessing cervical lymph node status in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-023-05470-y
doi: 10.1007/s00432-023-05470-y pubmed: 37875746 pmcid: 10657302
Weiss MH, Harrison LB, Isaacs RS (1994) Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120:699–702. https://doi.org/10.1001/archotol.1994.01880310005001
doi: 10.1001/archotol.1994.01880310005001 pubmed: 8018319
Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM (2011) A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 47:320–324. https://doi.org/10.1016/j.oraloncology.2011.03.009
doi: 10.1016/j.oraloncology.2011.03.009 pubmed: 21459661
D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R, Head ND, Management G (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529. https://doi.org/10.1056/NEJMoa1506007
doi: 10.1056/NEJMoa1506007 pubmed: 26027881
Feng Z, Li JN, Li CZ, Guo CB (2014) Elective neck dissection versus observation in the management of early tongue carcinoma with clinically node-negative neck: a retrospective study of 229 cases. J Craniomaxillofac Surg 42:806–810. https://doi.org/10.1016/j.jcms.2013.11.016
doi: 10.1016/j.jcms.2013.11.016 pubmed: 24529348
Abu-Ghanem S, Yehuda M, Carmel NN, Leshno M, Abergel A, Gutfeld O, Fliss DM (2016) Elective neck dissection vs observation in early-stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 142:857–865. https://doi.org/10.1001/jamaoto.2016.1281
doi: 10.1001/jamaoto.2016.1281 pubmed: 27442962
Koerdt S, Rockl J, Rommel N, Mucke T, Wolff KD, Kesting MR (2016) Lymph node management in the treatment of oral cancer: analysis of a standardized approach. J Craniomaxillofac Surg 44:1737–1742. https://doi.org/10.1016/j.jcms.2016.08.002
doi: 10.1016/j.jcms.2016.08.002 pubmed: 27580851
Kesting M (2015). Oral cancer surgery: a visual guide. In Oral Cancer Surgery: A Visual Guide
Tam S, Amit M, Zafereo M, Bell D, Weber RS (2019) Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma. Head Neck-J Sci Spec 41:177–184. https://doi.org/10.1002/hed.25506
doi: 10.1002/hed.25506
Sakata J, Yamana K, Yoshida R, Matsuoka Y, Kawahara K, Arita H, Nakashima H, Nagata M, Hirosue A, Kawaguchi S, Gohara S, Nagao Y, Hiraki A, Shinohara M, Toya R, Murakami R, Nakayama H (2018) Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma. Hum Pathol 76:1–8. https://doi.org/10.1016/j.humpath.2017.12.021
doi: 10.1016/j.humpath.2017.12.021 pubmed: 29307623
Loganathan P, Sayan A, Hsu DWK, Paraneetharan S, Ilankovan V (2017) Squamous cell carcinoma of the anterior tongue: is tumour thickness an indicator for cervical metastasis? Int J Oral Maxillofac Surg 46:407–412. https://doi.org/10.1016/j.ijom.2016.11.003
doi: 10.1016/j.ijom.2016.11.003 pubmed: 27919662
Lop J, Rigo A, Codina A, de Juan J, Quer M, Leon X (2018) Prognostic significance of extranodal extension in head and neck squamous cell carcinoma cN0 patients with occult metastatic neck nodes. Acta Otorrinolaringol Esp (Engl Ed) 69:156–164. https://doi.org/10.1016/j.otorri.2017.07.002
doi: 10.1016/j.otorri.2017.07.002 pubmed: 29033121
de Bree R, Takes RP, Castelijns JA, Medina JE, Stoeckli SJ, Mancuso AA, Hunt JL, Rodrigo JP, Triantafyllou A, Teymoortash A, Civantos FJ, Rinaldo A, Pitman KT, Hamoir M, Robbins KT, Silver CE, Hoekstra OS, Ferlito A (2015) Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck 37:1829–1839. https://doi.org/10.1002/hed.23814
doi: 10.1002/hed.23814 pubmed: 24954811
Yang L, Liu F, Wu Y, Fang Q, Zhang X, Du W, Zhang X, Chen D, Luo R (2020) Predictive value of occult metastasis and survival significance of metabolic tumor volume determined by PET-CT in cT1-2N0 squamous cell carcinoma of the tongue. Front Oncol 10:542530. https://doi.org/10.3389/fonc.2020.542530
doi: 10.3389/fonc.2020.542530 pubmed: 33425715 pmcid: 7793868
Hutchison IL, Ridout F, Cheung SMY, Shah N, Hardee P, Surwald C, Thiruchelvam J, Cheng L, Mellor TK, Brennan PA, Baldwin AJ, Shaw RJ, Halfpenny W, Danford M, Whitley S, Smith G, Bailey MW, Woodwards B, Patel M, McManners J, Chan CH, Burns A, Praveen P, Camilleri AC, Avery C, Putnam G, Jones K, Webster K, Smith WP, Edge C, McVicar I, Grew N, Hislop S, Kalavrezos N, Martin IC, Hackshaw A (2019) Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. Br J Cancer 121:827–836. https://doi.org/10.1038/s41416-019-0587-2
doi: 10.1038/s41416-019-0587-2 pubmed: 31611612 pmcid: 6888839
de Matos LL, Manfro G, dos Santos RV, Stabenow E, de Mello ES, Alves VAF, Pinto FR, Kulcsar MAV, Brandao LG, Cernea CR (2014) Tumor thickness as a predictive factor of lymph node metastasis and disease recurrence in T1N0 and T2N0 squamous cell carcinoma of the oral tongue. Or Surg or Med or Pa 118:209–217. https://doi.org/10.1016/j.oooo.2014.03.023
doi: 10.1016/j.oooo.2014.03.023 pubmed: 24906946
Kane SV, Gupta M, Kakade AC, Cruz AD (2006) Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Ejso-Eur J Surg Onc 32:795–803. https://doi.org/10.1016/j.ejso.2006.05.004
doi: 10.1016/j.ejso.2006.05.004
Alvarez Amezaga J, Barbier Herrero L, Pijoan del Barrio JI, Martin Rodriguez JC, Romo Simon L, Genolla Subirats J, Rios Altolaguirre G, de los Rios A, ArteagoitiaCalvo I, LandaLlona S, Arruti Gonzalez JA, Lopez Cedrun J, Santamaria Zuazua J (2007) Diagnostic efficacy of sentinel node biopsy in oral squamous cell carcinoma. Cohort study and meta-analysis. Med Oral Patol Oral Cir Bucal 12:E235-243
pubmed: 17468723
Chien CY, Wang CP, Lee LY, Lee SR, Ng SH, Kang CJ, Lin JC, Terng SD, Hua CH, Chen TM, Chen WC, Tsai YT, Tsai CY, Chu YH, Lin CY, Fan KH, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Wen YW, Liao CT (2023) Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: a nationwide study. Oral Oncol 140:106366. https://doi.org/10.1016/j.oraloncology.2023.106366
doi: 10.1016/j.oraloncology.2023.106366 pubmed: 36965411
Schilling C, Stoeckli SJ, Haerle SK, Broglie MA, Huber GF, Sorensen JA, Bakholdt V, Krogdahl A, von Buchwald C, Bilde A, Sebbesen LR, Odell E, Gurney B, O’Doherty M, de Bree R, Bloemena E, Flach GB, Villarreal PM, Fresno Forcelledo MF, Junquera Gutierrez LM, Amezaga JA, Barbier L, Santamaria-Zuazua J, Moreira A, Jacome M, Vigili MG, Rahimi S, Tartaglione G, Lawson G, Nollevaux MC, Grandi C, Donner D, Bragantini E, Dequanter D, Lothaire P, Poli T, Silini EM, Sesenna E, Dolivet G, Mastronicola R, Leroux A, Sassoon I, Sloan P, McGurk M (2015) Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer 51:2777–2784. https://doi.org/10.1016/j.ejca.2015.08.023
doi: 10.1016/j.ejca.2015.08.023 pubmed: 26597442
Sagheb K, Sagheb K, Rahimi-Nedjat R, Taylor K, Al-Nawas B, Walter C (2016) Sentinel lymph node biopsy in T1/T2 squamous cell carcinomas of the tongue: a prospective study. Oncol Lett 11:600–604. https://doi.org/10.3892/ol.2015.3933
doi: 10.3892/ol.2015.3933 pubmed: 26870253
Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P (2003) A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39:350–360. https://doi.org/10.1016/s1368-8375(02)00121-5
doi: 10.1016/s1368-8375(02)00121-5 pubmed: 12676254
Gallegos-Hernandez JF, Hernandez-Hernandez DM, Flores-Diaz R, Sierra-Santiesteban I, Pichardo-Romero P, Arias-Ceballos H, Minauro-Munoz G, Alvarado-Cabrero I (2005) The number of sentinel nodes identified as prognostic factor in oral epidermoid cancer. Oral Oncol 41:947–952. https://doi.org/10.1016/j.oraloncology.2005.05.010
doi: 10.1016/j.oraloncology.2005.05.010 pubmed: 16051515
Ross GL, Soutar DS, Gordon MacDonald D, Shoaib T, Camilleri I, Roberton AG, Sorensen JA, Thomsen J, Grupe P, Alvarez J, Barbier L, Santamaria J, Poli T, Massarelli O, Sesenna E, Kovacs AF, Grunwald F, Barzan L, Sulfaro S, Alberti F (2004) Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 11:690–696. https://doi.org/10.1245/ASO.2004.09.001
doi: 10.1245/ASO.2004.09.001 pubmed: 15197011
Alkureishi LW, Burak Z, Alvarez JA, Ballinger J, Bilde A, Britten AJ, Calabrese L, Chiesa C, Chiti A, de Bree R, Gray HW, Hunter K, Kovacs AF, Lassmann M, Leemans CR, Mamelle G, McGurk M, Mortensen J, Poli T, Shoaib T, Sloan P, Sorensen JA, Stoeckli SJ, Thomsen JB, Trifiro G, Werner J, Ross GL (2009) European Association of Nuclear Medicine Oncology C, European Sentinel Node Biopsy Trial C Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 16:3190–3210. https://doi.org/10.1245/s10434-009-0726-8
doi: 10.1245/s10434-009-0726-8 pubmed: 19795174 pmcid: 2766455
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850. https://doi.org/10.1002/hed.20279
doi: 10.1002/hed.20279 pubmed: 16161069
Carlton JA, Maxwell AW, Bauer LB, McElroy SM, Layfield LJ, Ahsan H, Agarwal A (2017) Computed tomography detection of extracapsular spread of squamous cell carcinoma of the head and neck in metastatic cervical lymph nodes. Neuroradiol J 30:222–229. https://doi.org/10.1177/1971400917694048
doi: 10.1177/1971400917694048 pubmed: 28627989 pmcid: 5480800
Chai RL, Rath TJ, Johnson JT, Ferris RL, Kubicek GJ, Duvvuri U (2013) Branstetter BFt Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck. JAMA Otolaryngol Head Neck Surg 139:1187–1194. https://doi.org/10.1001/jamaoto.2013.4491
doi: 10.1001/jamaoto.2013.4491 pubmed: 24076619
Haidari S, Obermeier KT, Kraus M, Otto S, Probst FA, Liokatis P (2022) Nodal disease and survival in oral cancer: is occult metastasis a burden factor compared to preoperatively nodal positive neck? Cancers (Basel) 14. https://doi.org/10.3390/cancers14174241
Broglie MA, Haerle SK, Huber GF, Haile SR, Stoeckli SJ (2013) Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival. Head Neck 35:660–666. https://doi.org/10.1002/hed.23017
doi: 10.1002/hed.23017 pubmed: 22605675
Liu JY, Chen CF, Bai CH (2019) Elective neck dissection versus observation in early-stage (cT1/T2N0) oral squamous cell carcinoma. Laryngoscope Investig Otolaryngol 4:554–561. https://doi.org/10.1002/lio2.301
doi: 10.1002/lio2.301 pubmed: 31637301 pmcid: 6793606
Liu X, Lao X, Liang L, Zhang S, Li K, Liao G, Liang Y (2017) Neck observation versus elective neck dissection in management of clinical T1N0 oral squamous cell carcinoma: a retrospective study of 232 patients. Chin J Cancer Res 29:179–188. https://doi.org/10.21147/j.issn.1000-9604.2017.03.03
doi: 10.21147/j.issn.1000-9604.2017.03.03 pubmed: 28729768 pmcid: 5497204
Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO (1994) Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 168:391–394. https://doi.org/10.1016/s0002-9610(05)80082-0
doi: 10.1016/s0002-9610(05)80082-0 pubmed: 7977957
Flach GB, Tenhagen M, de Bree R, Brakenhoff RH, van der Waal I, Bloemena E, Kuik DJ, Castelijns JA, Leemans CR (2013) Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: no survival difference as compared to elective neck dissection. Oral Oncol 49:157–164. https://doi.org/10.1016/j.oraloncology.2012.08.006
doi: 10.1016/j.oraloncology.2012.08.006 pubmed: 22967965
Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR (2002) Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 24:282–289. https://doi.org/10.1002/hed.10018
doi: 10.1002/hed.10018 pubmed: 11891961
Ho CM, Lam KH, Wei WI, Lau SK, Lam LK (1992) Occult lymph node metastasis in small oral tongue cancers. Head Neck 14:359–363. https://doi.org/10.1002/hed.2880140504
doi: 10.1002/hed.2880140504 pubmed: 1399568
Gane EM, Michaleff ZA, Cottrell MA, McPhail SM, Hatton AL, Panizza BJ, O’Leary SP (2017) Prevalence, incidence, and risk factors for shoulder and neck dysfunction after neck dissection: a systematic review. Eur J Surg Oncol 43:1199–1218. https://doi.org/10.1016/j.ejso.2016.10.026
doi: 10.1016/j.ejso.2016.10.026 pubmed: 27956321
Dedivitis RA, Guimaraes AV, Pfuetzenreiter EG Jr, Castro MA (2011) Neck dissection complications. Braz J Otorhinolaryngol 77:65–69. https://doi.org/10.1590/s1808-86942011000100011
doi: 10.1590/s1808-86942011000100011 pubmed: 21340191
Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B (2009) Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck 31:503–512. https://doi.org/10.1002/hed.21001
doi: 10.1002/hed.21001 pubmed: 19156833

Auteurs

Ann-Kristin Struckmeier (AK)

Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany. ann-kristin.struckmeier@uk-erlangen.de.
Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany. ann-kristin.struckmeier@uk-erlangen.de.

Mayte Buchbender (M)

Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.

Tobias Moest (T)

Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.

Rainer Lutz (R)

Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.

Abbas Agaimy (A)

Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.
Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Marco Kesting (M)

Department of Oral and Cranio-Maxillofacial Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Glückstraße 11, 91054, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Erlangen, Germany.

Classifications MeSH